Literature DB >> 11175655

A practical approach for evaluating new antibodies in the clinical immunohistochemistry laboratory.

E D Hsi1.   

Abstract

Paraffin section immunohistochemistry (IHC) is widely used in diagnostic surgical pathology. Today, it is difficult to imagine the practice of surgical pathology without IHC. The availability of automated immunostainers with reagent rental contracts makes this technology commonplace. One potential danger is that many laboratories are now offering immunostains without significant prior knowledge or experience in IHC. As part of its mission, the Cell Markers Committee of the College of American Pathologists offers this manuscript as a basic guide to introducing new antibodies in the clinical IHC laboratory. Issues relating to regulatory developments, antibody selection, staining optimization, and test validation are addressed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11175655     DOI: 10.5858/2001-125-0289-APAFEN

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

Review 1.  In situ hybridization in the pathology laboratory: general principles, automation, and emerging research applications for tissue-based studies of gene expression.

Authors:  David G Hicks; Gabe Longoria; James Pettay; Tom Grogan; Shannon Tarr; Raymond Tubbs
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

Review 2.  Antibody validation.

Authors:  Jennifer Bordeaux; Allison Welsh; Seema Agarwal; Elizabeth Killiam; Maria Baquero; Jason Hanna; Valsamo Anagnostou; David Rimm
Journal:  Biotechniques       Date:  2010-03       Impact factor: 1.993

Review 3.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

4.  Analytic variability in immunohistochemistry biomarker studies.

Authors:  Valsamo K Anagnostou; Allison W Welsh; Jennifer M Giltnane; Summar Siddiqui; Camil Liceaga; Mark Gustavson; Konstantinos N Syrigos; Jill L Reiter; David L Rimm
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

5.  Cancer cell profiling by barcoding allows multiplexed protein analysis in fine-needle aspirates.

Authors:  Adeeti V Ullal; Vanessa Peterson; Sarit S Agasti; Suan Tuang; Dejan Juric; Cesar M Castro; Ralph Weissleder
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

6.  Immunohistochemistry as an important tool in biomarkers detection and clinical practice.

Authors:  Leandro Luongo de Matos; Damila Cristina Trufelli; Maria Graciela Luongo de Matos; Maria Aparecida da Silva Pinhal
Journal:  Biomark Insights       Date:  2010-02-09

7.  Expanded clinical and experimental use of SOX11 - using a monoclonal antibody.

Authors:  Lena Nordström; Ulrika Andréasson; Mats Jerkeman; Michael Dictor; Carl Borrebaeck; Sara Ek
Journal:  BMC Cancer       Date:  2012-06-27       Impact factor: 4.430

8.  Transplantation of autologous bone marrow-derived mesenchymal stem cells for traumatic brain injury.

Authors:  Jindou Jiang; Xingyao Bu; Meng Liu; Peixun Cheng
Journal:  Neural Regen Res       Date:  2012-01-05       Impact factor: 5.135

9.  Proof of the quantitative potential of immunofluorescence by mass spectrometry.

Authors:  Maria I Toki; Fabiola Cecchi; Todd Hembrough; Konstantinos N Syrigos; David L Rimm
Journal:  Lab Invest       Date:  2017-01-16       Impact factor: 5.662

10.  Epo receptors are not detectable in primary human tumor tissue samples.

Authors:  Steve Elliott; Susan Swift; Leigh Busse; Sheila Scully; Gwyneth Van; John Rossi; Carol Johnson
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.